COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update

Repositioned as a pure-play natural-based product company following strategic review and pipeline prioritization

Efforts continue to gain efficiencies through streamlining and cost cutting measures; Company ended the quarter with US$13.8 million in cash

Read more at globenewswire.com